Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary disease-Reference-Cited by-同舟云学术

Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary disease

Published:2006-04-19 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Appleton Sarah¹,Jones Terry²,Poole Phillippa³,Pilotto Louis⁴,Adams Robert⁵,Lasserson Toby J⁶,Smith Brian J⁷,Muhammed Julia⁸

Affiliation:

1. The Queen Elizabeth Hospital; Deptartment of Medicine; Woodville Road Adelaide South Australia Australia 5011

2. The Queen Elizabeth Hospital; Adelaide Australia

3. University of Auckland; Department of Medicine; Private Bag 92019 Auckland New Zealand

4. The Queen Elizabeth Hospital; Clinical Epidemiology and Health Outcomes Unit; Adelaide South Australia Australia 5011

5. The Queen Elizabeth Hospital; Department of Medicine; Woodville Road Adelaide South Australia Australia 5011

6. Cochrane Central Executive; Editorial & Methods Department; St Albans House 57-59 Haymarket London UK SW1Y 4QX

7. The Queen Elizabeth Hospital, Central Adelaide Local Health Network; Respiratory Medicine Unit; Adelaide Australia

8. University of Adelaide; C/O Department of Medicine; Adelaide Australia

Publisher

Wiley

Subject

Pharmacology (medical)

Reference76 articles.

1. For COPD a combination of ipratropium bromide and albuterol sulfate is more effective than albuterol base;Campbell;Archives Internal Medicine,1999

2. Brown D A randomized, double blind, parallel, multi-centre comparison of inhalation solution with albuterol inhalation solution following single-dose and chronic administration (85 days) in patients with chronic obstructive pulmonary disease Boehringer Ingelheim unpublished report USA U91-0865 1991

3. Nebulized bronchodilators for outpatient management of stable chronic obstructive pulmonary disease;Colice;The American Journal of Medicine,1996

4. Extended therapy with ipratropium is associated with improved lung function in patients with COPD. A retrospective analysis of data from seven clinical trials;Rennard;Chest,1996

5. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone;"COMBIVENT" Inhalation Aerosol Study Group;Chest,1994

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drugs Acting on Autonomic Nervous System;Essentials of Pharmacodynamics and Drug Action;2024

2. Federal guidelines on diagnosis and treatment of chronic obstructive pulmonary disease;PULMONOLOGIYA;2022-07-13

3. The use of Ipratropium and Tiotropium as novel agents to reduce inflammation in in vitro macrophage models;2021-11-02

4. The use of short-acting bronchodilators in patients with chronic bronchoobstructive pathology at the present stage;Meditsinskiy sovet = Medical Council;2021-09-19

5. Inhaled Medications Employed in Critically Ill Patients;Essentials of Aerosol Therapy in Critically ill Patients;2021